throbber
fsmm
`
`360 Journal of Medicinal Chemistry, 1991, Vol 34, No. 1
`
`Roth et ai
`
`Table I
`
`RA^OR*
`
`X n N^^Ra
`
`y\//
`Ri
`
`X
`H
`H
`H
`F
`
`mp,"-6 0C
`% yield (method)
`no.
`R*
`R t
`Ra
`R2
`75(A)
`olF
`-CHJCHJ-
`Ph
`6a
`CHj
`COjEt
`36(A)
`oil5
`-CHJCHJ-
`fib
`Et
`Ph
`COjEt
`4(A)
`oU*
`COjEt
`-CHJCHJ-
`6c
`Pr
`Ph
`65(B)
`143-6
`COJCHJ
`11a
`Pr
`COJCHJ
`-CHJCHJ-
`70(B)
`COjEt
`lib
`i-Pr
`COjEt
`-CHjCHf-
`Oil4
`30(B)
`Ph
`146-8
`/•Pr
`-CH2CH2-
`He
`COjEt
`45(C)
`-CHJCHJ-
`158-9
`16a
`Pr
`Ph
`COjEt
`51(C)
`on*
`16b
`Pr
`COjCHjPh
`-CHJCHJ-
`Ph
`43(C)
`CONHPh
`-CH2CH2-
`161-3
`16c
`Pr
`Ph
`COjEt
`i-Pr
`-CH2CHJ-
`oil'
`16d
`4'CNPh
`88(C)
`64(D)
`oil*
`CH3
`Pr
`CH,
`-CHJCHJ-
`18
`71(E)
`Et
`84-7
`H
`i-Pr
`Ph
`23a
`Et
`76(E)
`Pr
`2*pyridyl
`84-6
`H
`23b
`Et
`i-Pr
`S-pyridyl
`64(E)
`96-8
`H
`F
`23c
`Et
`46(E)
`4-pyTidyl
`123-5
`Pr
`F
`23d
`H
`"All compounds possess 'H NMR spectra consistent with assigned structure. &Combustion analyses within ±0-4% of theoretical unless
`otherwise noted. 'This compound was pmified, but not analyzed before use hi the next step.
`
`F
`F
`F
`F
`F
`F
`F
`
`CHO
`
`N
`
`Rg
`
`f"1
`t\ n
`
`Table 11
`
`X. n
`
`Rs
`Kt
`Ra % yield mp^'C
`Rt
`no. X
`77
`7a
`H Ph
`CHj
`COjEt
`100-1
`oii<
`7b
`H Ph
`Et
`COjEt
`88
`7G
`oil'
`i-Pr
`K Ph
`100
`COjEt
`COSCH3
`90
`oilf
`i-Pr
`12a F C02CH3
`95
`i-Pr
`12b F COsEt
`COjEt
`oil'
`oil*
`90
`Ph
`i-Pr
`12c F COjEt
`127-8
`17a F Ph
`81
`i-Pr
`COjEt
`oile
`17b F Ph
`COjCH^h
`i-Pr
`60
`164-5
`17c F Ph
`CONHPh
`86
`i-Pr
`75
`oile
`17d F 4«CNPh
`i-Pr
`COjEt
`i-Pr
`oilc
`F CHj
`66
`19
`CH3
`85
`oile
`i-Pr
`24a F Ph
`H
`70
`24b F 2-pyridyl H
`i-Pr
`120-2
`93
`24c F 3-pyridyl H
`oil*
`i-Pr
`95
`oil*
`i-Pr
`24d F 4-pyridyl H
`i-Pr
`Ph
`oU*
`90
`28
`F H
`aAll compounds possessed ^ NMR and IR spectra consistent
`with assigned structure. ''Combustion analyes within ±0.4% of
`theoretical unless otherwise noted. 'This compound was purified
`by chromatography, but not analyzed before use in the next step.
`
`VIII).16 Thus, reaction of aldehyde 17c with the mag­
`nesium enolate of GSH+)'2-acetoxy-l»l,2-triphenylethanol
`afforded alcohol 31 in 60% yield and 97% ee. Trans-
`esterification (NaOCHa, CH3OH) followed by Claisen
`condensation with excess lithio tert-butylacetate produced
`-5-hydroxy-jS-keto ester 32 in 75% yield. After reduction
`with EtsB and NaBH^ base hydrolysis, and lactonization, •
`(+)-33 was isolated as a 98:2 mixture of stereoisomers.
`Fortuitously, the 6,1 pair selectively crystallized from ethyl
`acetate-hexanes and pure (+)-33 ([cr]2^ = +24.53°, 0.53%
`in CHCI3) could then be isolated from the mother liquors
`as a foamy solid.17
`
`'
`
`(16) Braun, M.; Devant, R. Tetrohedren Lett. 1984, 5031^<j g
`
`Scheme Vnr
`
`CHO
`
`p.
`
`01 J
`
`Ph
`
`F.
`
`7 -
`D1 i
`
`to
`
`Pn'
`
`JONHPn
`
`Pn'
`
`CONHPn
`
`n7e
`
`31
`
`F.
`
`HO,
`
`ol i
`
`XOjJBu
`
`o
`
`a-B '
`
`Pn'
`
`'CONHPn
`
`sa
`
`P. ar
`
`pn'
`
`CONHPn
`
`{*)•33
`
`O
`?H
`1
`•(a) CHj^oJcPh, 2LDA, MgBra. -78 •C; (b) NaOCHal
`Ph
`r
`Ph
`
`OLi
`(c) •^'OtBu (d) EtjB. NaBH; (e) HJOJ, CHaOH; (i) NaOH: (s) PhCH3, rellux.
`
`propane" and deprotection (Scheme VI, method E). Fi­
`nally, the 3,4-dichloro, 3,4-dibromo, and 3-trifluoroacetyl
`analogues (30a-c) were prepared from 1 by protection of
`the 4/-hydroxyl as the tert-butyldimethylsilyl ether, fol­
`lowed by electrophilic substitution on the pyrrole ring15
`and deprotection with n-6u4NF buffered with acetic acid
`(Scheme VII). The assignment of the regiochemistry of
`30c was made in a manner analogous to 11c and lid.
`• Chiral lactone (+)-33 was prepared by application of the
`asymmetric aldol procedure developed by Braun (Scheme
`
`(13) Broadbent, K. S.; Burnham, W. S.; Olsen, R. K.; Sheeley, R.
`M. J. Hetemycl. Chem. 1968,5, 757-67.
`(14) Suzuki, E.; Inone, 3.; Goto, T. Chem. Pkarm. Bull. 1968,76,
`933-8.
`(15) Aiello, E.; Dattolo, G.; Cirrincione, G.; Almerico, A. M.; D'As*
`dia, I. J. Hftencycl. Chem. 1982, 19, 977-9.
`
`i-1
`
`V'!:.
`'T"
`- v
`
`Sawai Ex 1005
`Page 3012 of 4322
`
`

`
`^
`
`ftl
`&
`
`i#!:.
`
`inhibitors 0/ Cholesterol Biosynthesis. 3
`
`Joumai 0/ Medicinal Chemistry, 1992, Vol. 34, No. 1 361
`
`Table III
`
`HQ ty
`r u N Rj
`
`\ /
`fi2
`
`X
`
`no.
`( 1.
`3b
`3c
`3d
`3e
`3f
`3g
`3h
`0i:)-3i
`3j
`3k
`31
`Sin
`3n
`3o
`3p
`30a
`30b
`30c
`(+)-33
`(-)-33
`
`X
`F
`H
`H
`H
`F
`F
`F
`F
`F
`F
`
`F
`F
`F
`F
`F
`F
`F
`F
`F
`F
`F
`
`Ri
`
`R4
`
`H
`C02Et
`CO:Et
`COjEt
`COJCHJ
`COjEt
`Ph
`COjEt
`COjCHjPh
`CONHPh
`COjEt
`CHj
`H
`H
`H
`H
`Ph
`ci
`Br
`H
`CONHPh
`CONHPh
`
`relative
`potency*
`ICgo + jtM
`H
`10.9
`023
`Ph
`0.6
`4.0
`Ph
`6.3
`089
`Ph
`23.5
`017
`COJCH3
`14^
`0.180
`COjEt
`0.35
`2.8
`C02Et
`100
`0.050
`Ph
`35.5
`0.20
`Ph
`0.040
`24.0
`Ph
`81.4
`0.025
`4-CN-Ph
`0.280
`16^
`0140
`16.0
`CHa
`0347
`Ph
`12.5
`2-pyridyl
`0.046
`76
`9.4
`3-pyridyl
`0071
`4-pyridyl
`0310
`2.1
`36.3
`H
`0120
`a
`78.6
`0028
`0.028
`78.6
`Br
`0.800
`COCF,
`8.8
`500
`0.007
`Ph
`13.9
`Ph
`0.440
`100
`0.030
`eompactin
`'Analytical results are within ±0.4% of theoretical values except where otherwise noted. 6CoA reductase Inhibition (COR) screen; a
`measure of the direct conversion of D,L-[MC]HMG-COA to mevalonic add. Assays of each inhibitor were performed at four concentrations
`in triplicate. The precision for eompactin was 37%. See ref 7 for experimental details. 'Calculated as follows: (ICM of compactin/ICjo of
`test compound determined simultaneously) x 100. Compactin arbitrarily assigned a value of 100.
`
`R3
`».Pr
`CHj
`Et
`i-Pr
`ffi
`i-Pr
`»-Pr
`».Pr
`i«Pr
`i-Pr
`j-Pr
`j.Pr
`i-Pr
`i-Pr
`».Pr
`».Pr
`i-Pr
`i-Pr
`{•Pr
`i-Pr
`
`mp, 0C
`105-6
`©U
`69-8
`157-9
`169-170
`121-3
`158-9
`159-160
`174-5
`104-110
`oil
`oil
`oil
`186-7
`70-4
`174-6
`135-6
`129-131
`141.2
`oil
`foam
`foam
`
`formula"
`CMHMFNO,
`C^HJJNOS
`CaH^NOj
`CaH^NOs
`CMHMFNO,
`CajH^PNO,
`CJJHJJFNOS .
`CJSHMFNQS
`QMH^FNOS
`C^HaFN^O,
`CaoHajFNjOj '
`CaHaFNOa
`CKHMFNO,
`CJSHJTFNA
`CjjHnFNjOa
`CJJHJTFNJOJ
`CaHjjFNO,
`CMHaCUFNOj
`Ca)HKBrjFNOa
`C2AHOF4N0,
`CsHsFNA
`CSHJJFNA
`
`'
`
`Alternatively, relatively pure (+)- and (-)-33 could be
`obtained by preparation of the corresponding diastereo-
`meric (flj-fr-methylbenzylamides, separation by prepara­
`tive HPLC, hydrolysis, and relactomzation.6b This process
`afforded 94.6% pure (+)-33 ([a]2^ = +25.5°, 0.51% in
`CHClg) and 97.8% pure (-)-33 ([a]2^ = -24.8% 0.51% in
`CHCI3).
`Biological Results and Discussion
`The compounds listed in Table III were all hydroly2ed
`to the corresponding dihydroxy acid sodium salts and
`evaluated for their ability to inhibit a partially purified-
`preparation of rat liver HMG-CoA reductase.3 Two con­
`clusions were readily apparent. The first was the confir­
`mation of the 5-isopropyl as the preferred substituent
`(compare 3c with 3a and 3b). The second was the sig­
`nificant increase in in vitro potency found with the in­
`troduction of certain lipophilic electron-withdrawing
`groups into the 3 and 4 positions of the pyrrole ring (e.g.,
`CI or Br, compare 1 with 30a and 30b), such that, these
`compounds displayed potency equivalent to compactin.
`This effect did not hold for the esters or ketones (COjMe,
`CO^Et, COCF3, compounds 3d, 3e, 30c), except when
`combined with a phenyl (compounds 3f, 3h, and 3i). There
`also appeared to be a positional effect, since the 3-carb-
`ethoxy-4-phenyl analogue (3f) was 4 times more potent
`than the 3*phenyl-4-carbethoxy analogue (3g). In vitro
`activity for the 3-phenyl analogues were improved sig­
`
`(17) A similer sequence was employed by Lynch et al.: Lynch, J.
`E.; Volante, R. P.; Wattley, R. V.; Shinkai, 1. Tetrahedron
`Lett. 1987,1385-8.
`
`nificantly by increasing the size of the 4-substituent
`(compare 3h, 3i, and 3g with 31). Potency was also in*
`creased when the 3-phenyl was replaced with a 3-(2>
`pyridyl) moiety (compound 3m). The 3-(3- and 4-pyridyl)
`isomers (3n and 3o) were equipotent to phenyl (31). In­
`troduction of the electron-withdrawing cyano group into
`the 4-position of the 3-phenyl (35) led to a slight reduction
`in potency. Finally, as others have reported, in the case
`of 31 essentially all of the biological activity was contained
`in the dextrorotatory stereoisomer ((+)-33 vs 3i).6b We
`speculate that the activity found in (-)-33 (97.8% pure)
`is derived from the 2% contamination with (+)-33.
`An attempt was made to confirm these observations with
`a quantitative structure-reactivity relationship (QSAR)
`analysis. In the early stages of the development of the
`series, there was an indication that size, as parameterized
`by MR of the combined 3* and 4-substituents, as well as
`electronic-withdrawing character might be possible con­
`tributors to activity and this preliminary analysis partially
`guided further synthesis. Synthetic constraints precluded
`the preparation of an optimally designed set, however, and
`the set of compounds described in this paper did not ul­
`timately support the derivation of a significant Hansch
`equation including these parameters. Furthermore,
`available parameters for electronic and lipophilic effects
`of these highly hindered functional groups are likely to be
`seriously inaccurate. Nevertheless, the trends observed
`from plots and single parameter correlations supported the
`observation that a size benefit exists, but derives mainly
`from the 4-substituent, as opposed to the 3-substituent.
`Polar functionality can be tolerated in this region, although
`suggestion that lipophilicity may ultimat^^ay
`there is a
`
`1
`
`•
`
`•.
`
`• •
`
`W-
`.••M IK
`
`r n i m . . . . *
`
`id
`
`r;
`
`i
`
`jj
`
`Sawai Ex 1005
`Page 3013 of 4322
`
`

`
`mw •••{
`m
`
`BMBwaaawgwaM
`
`362 Journal of Medicinal Chemistry, 1991, Vol. 34, No. J
`
`the dominant role among-the simple parameterized effects,
`since Pi^4 has one of the best single parameter correlations
`with activity (r = 0.46). Clearly, other factors not readily
`parameterized have equal or larger influence on relative
`activity in this series. The activity of polar-substituted
`analogues is enhanced when the polar group is "insulated"
`from the enzyme as in 3in vs 3a and 3o. Similarly, the
`better activity of 3f over 3g may derive from the better
`shielding of the polar ester group in the former compound
`by the flanking phenyl groups as opposed to a phenyl and
`isopropyl group in the latter. The activity of the halo-
`genated analogues 30a and 30b is better accommodated
`by a lipophilidty effect, rather that a size or dispersion
`effect reflected in MR. Other QSAR analyses of synthetic
`HMG-CoA reductase inhibitors have reached similar
`conclusions about structural variations in this region of
`related molecules.18-19
`In conclusion, although it is still most critical in this type
`to have the optimal substituents flanking the dihydroxy-
`glutarate side ftham, ie., 4-fiuorophenyl and isopropyl,7 this
`work shows that further modulation and improvement in
`potency at inhibiting HMG-CoA reductase may be ob­
`tained with a variety of additional substituents capable
`of interacting with an apparently fairly spacious hydro­
`phobic region distal from the side-chain location. The
`importance of this interaction is further supported by the
`potent inhibition evidenced by other inhibitors which
`possess substituents in this region.1 Preparation of the
`optically pure H^R-isomer ((+)«33) of the most potent
`compound in this series (3i) resulted in a compound which
`was 5 times more potent than the fungal metabolite com-
`pactin in vitro. Further in vivo studies with (+)-33 will
`be described in subsequent papers from this laboratory.
`Experimental Section
`'
`Unless otherwise noted, roaterials were obtained from com­
`mercial suppliers and were used without further purification. THF
`was distilled from sodium and benzophenone. All organic extracts
`were dried over MfS04 except when otherwise noted. Melting
`points were determined on a Thomas Hoover melting point ap­
`paratus and are uncorrected. Infrared spectra were determined
`on a Nicolet MX-1FT-IR spectrophotometer. NMR spectra were
`determined on either a Varian EM-39Q spectrometer, or a Varian
`XL-200 or Bruker 250 MHz instrument Chemical shifts are
`expressed as parts per million downfield from internal tetra-
`methylsilane. Elemental analyses for-carbon, hydrogen, and
`nitrogen were determined on a Perkin-Elmer Model 240C ele­
`mental analyzer and are within 0.4% of theory unless noted
`otherwise. Optical rotations were determined with use of a
`Perkin-Elmer 241 polarimeter. Routine HPLC analyses were
`performed with use of a Varian 5500 unit equipped with a Beodyne
`7126 loop injector, a Dupont variable wavelength detector, and
`an octadecylsSane (AUtech CIS 600RP, CH3CN-H2O eluant, 60:40,
`v/v) or silica gel column (Beckman Aitex Ultrasphere 5 pm)
`interfaced to Varian 402 data system for computation of peak
`areas. Chiral HPLC analyses were performed with use of a
`Cbiracel of lO-pm column (Diacel Chem. Ind., LTD).
`Method A. Ethyl 3-[2-(l^-Dioxolan-2-yl)ethyl]amino-2-
`pentenoate (4b). A solution of methyl propionylacetate (12£5
`mL, 100 mxnol), 2-(2-aimnoethyD*l,3-dioxolane8 (12.3 g, 105 mmol)
`and one drop of glacial acetic acid was stirred and heated in
`refluxing toluene (200 mL) for 2 h with azeotropic removal of
`water. The cooled solution was concentrated to provide 24 g of
`pure 4b, which was used without further purification.
`Ethyl 2-Ethyl-l-{2-(lf3-dioxolBii-2-yl)ethyl3-4^diphenyl-
`IH-pyrrole-S-carboxylate (6b). A mixture of benzoin (4.25 g,
`20 mmol), 4b (5.44 g, 22 mmol), and ZnClj (6 g, 44 mmol) in 50
`
`(18) Aggarwal, D.; Saha, R. N.; Gupta, J. K.; Gupta, S. P. <7.
`Pharmaeobio-Dyn. 1988,31, 591.
`(19) Prabbakar, Y. S.; Saxena, A K.; Doss, M. J. Drug Des. Deliv.
`1989,4,97;
`
`Roth et al.
`
`y
`
`mL of absolute ethanol was stirred and heated at reflux for 48
`h. The cooled solution was diluted with ether (500 mL), washed
`with water (50 mL), 2 M HC1 (2 X 50 mL), saturated aqueous
`bicarbonate (50 mL), and brine (50 mL), and dried. Flash
`chromatography (silica gel, 10:1 v/v hexane-ethyl acetate) pro­
`vided 3 g (36%) of 6b: 90-MHz NMR (CDClj) 5 0.98 (t, 3 H, J
`= 7 Hz), 1.34 (t, 3 H, J = 7 Hz), 1.85 (m, 2 H), 3.08 (q, 2 H, J
`= 7 Hz), 3.7-4.1 (m, 8 H), 4.60 (t, 1 H, J = 4 Hz), 7.1 (s, 5 H),
`7.22 (s, 5 H) ppm.
`Ethyl 2-£tbyl-l-[l-(3-oxopropyl)]-4,5-dipheny]-lir-
`pyrrole-3-carboxylate (7b). A solution of 6b (2.4 g, 5.7 mmol)
`in 100 mL of absolute ethanol containing 1 drop of concentrated
`HC1 was stirred and heated at reflux for 24 h. The cooled solution
`was concentrated and dissolved in 125 mL of 4:1 acetone-water,
`and 1 g of p-TSA-HsO was added. The resulting solution was
`stirred and heated at reflux for 24 h. The cooled solution was
`concentrated and partitioned between ether and water. The ether
`layer was then washed with saturated aqueous bicarbonate and
`brine and dried. Filtration and concentration afforded 1.9 g of
`7b (88%): 90-MHz NMR (CDCia) 61.0 (t, 3 H, J = 7 Hz), 1.28
`(t, 3 H, J = 7 Hz), 2.58 (m, 2 H), 3.10 (q 2 H, J = 7 Hz), 4.05 (q,
`2 H, J = 7 Hz), 4.2 (m, 2 H), 7.05 (s, 5 H), 7.1-7.4 (m, 5 H), 9.50
`(s, 1 H) ppm.
`Ethyl 3-[[2-(l,3-Dioxolan-2-yl)etbyl]ammo]-4-methyl-2-
`pentanoate (4c). A solution of ethyl isobutyrylacetate (6 g, 42
`mmol) and 2-(2-aminoethyl)-l,3-dioxolane (5.4 g, 46.7 nimol) in
`toluene (50 mL) containing 2 drops of glacial acetic acid was stirred
`and heated at reflux with azeotropic removal of water for 2 h.
`Concentration provided crude 4c which was used without further
`purification.
`Ethyl l-[2-(l,3-D:oxolan-2-yl)ethylJ-2-(]'methylethyl).
`4,5-diphenyl-lff-pyrrole-3-carboxylate (6c). A mixture of 4c
`(17 g, 80 mmol), benzoin acetate (75 mmol, 19 g), and ZnCij (20
`g, 147 mmol) in 100 mL of ethanol was stirred and heated at reflux
`for 2 days. The mixture was cooled to room temperature, poured
`into ether (1L), washed with water (200 mL), 2 M HC1 (100 mL),
`H20 (100 aL), and brine, and dried. Flash chromatography (silica
`gel, 10:1 v/v hexane-ethyl acetate) provided 1.2 g of 6c: 90-MHz
`NMR (CDCI3) 6 0.90 (t, 3 H, J =« 7 Hz), 1.45 (d, 6 H, J = 7 Hz),
`7 Hz), 3.8-4.1 (m, 8 H), 4.60
`1.90 (m, 2 H), 3.45 (septet, 1 H,
`(t, 1 H, J - 4 Hz), 7.0 (s, 5 H), 7.0-7.3 (m, 5 H) ppm.
`Ethyl l-(3-Oxopropyl)-5-(l-niethylethyl)-4,5-diphenyl-lH-
`pyrrole-3-carboxylate (7c). A solution of 6c (1.3 g, 3 mmol)
`and p-TSA-H20 (0.6 g, 3 mmol) in 50 mL of 4:1 acetone-water
`was stirred and heated at reflux overnight. The cooled mixture
`was poured into ether (200 mL), washed with saturated aqueous
`bicarbonate (2 X 50 mL), water (50 mL), and brine (50 mL), and
`dried. Filtration and concentration provided 1.0 g (100%) of pure
`7c which was used without further purification: 90-MHz NMR
`(CDCla) a 0.90 (t, 3 H, J = 7 Hz), 1.40 (d, 6 H, J = 7 Hz), 2.55
`<m, 2 H), 3.44 (septet, 1 H, J = 7 Hz), 3.95 (q, 2 H, J = 7 Hz),
`4.15 (m, 2 H), 7.0 (s, 5 H), 7-7.3 (m, 5 H), 9.43 (s, 1 H) ppm.
`Method B.
`JV-[2-(l,3-Dioxolan-2-yl)ethyl3-DL-valine,
`Methyl Ester (9). A solution of the methyl 2-hromo-3-
`methylbutyrate (4.6 g, 23.6 mmol), 2-(2-ammoethyl)-l,3-dioxolane
`(2.9 g, 25 mmol), and triethylamioe (3.5 mL, 25 mmol) in 25 mL
`of acetonitriie was stirred and heated at reflux for 20 h. The cooled
`solution was poured into ether (500 mL) and extracted with 2 M
`HQ (2 X 50 mL). The aqueous layer was made alkaline with 257o
`aqueous NaOH and extracted with ethyl acetate (2 X 100 mL).
`The combined ethyl acetate extracts were washed with brine and
`dried. Filtration and concentration provided 3 g (55%) of 9 as
`a yellow ofc 90-MHz NMR (CDCI3) S 0JB3 (d, J = 7 Hz, 6H), 1.70
`(br s, 1 H, 4NH), 1.86 (m, 2 H), 2.60 (m, 3 H), 2.94 (d, J « 6 Hz,
`1 H), 3.68 (s, 3 H), 3.85 (m, 4 H), 4.89 (t, J = 4 Hz, 1 H) ppm.
`iV-[2-(I^3-DioxoIan-2-y])ethyl]-Ar-(4-fluoroben2oyl)-DL-
`valine (10). To a stirred solution of 9 (3 g, 13 mmol) and tri-
`ethylamine (3.6 mL, 26 mmol) in 20 mL of CHjClj, cooled to 0
`0C, was added a solution of 4-fluorobenzoyl chloride (1.65 mL,
`14 mmol) in 10 mL of CHjCk* The solution was stirred 50 min
`at 0 0C and 60 min at room temperature. It was then poured into
`ether (200 mL), washed with water (2 X 50 mL), saturated aqueous
`bicarbonate (50 mL), and brine (50 mL), and dried. Hash
`chromatography (silica gel, 1:1 v/v hexane-ethyl acetate) provided
`3 g (65%) of crude (±)-methyl /v-(4-fluorobenzoyI)-N-[2-(2-
`ethyl)-l,3-dioxolanyl)vaUne: 90-MHz NMR (CDCI3) & O.Bfg^r
`
`M il. IP
`
`- : M
`
`Sawai Ex 1005
`Page 3014 of 4322
`
`

`
`Inhibitors of Cholesterol Biosynthesis. 3
`
`Journal of Medicinal Chemistry, 1991, Vol. 34, No. 1 363
`
`tiiethylamme. The resulting mixture was cooled to 0 0C under
`dry nitrogen. A solution of 11 mL (105 mmol) of isobutyiyl
`chloride in 50 mL of CHgCl: was slowly added with stirring. After
`addition was complete, the mixture was stirred for an additional
`1 h and then poured into 100 mL of ether. The ether solution
`was washed successively with water (25 mL), 2 M HC1 (25 mL),
`saturated aqueous bicarbonate (25 mL), and brine (25 mL), and
`dried. Filtration and evaporation of the solvents yielded 35 g of
`a-[[2-(l,3-dioxoIan-2-yl)ethyl](2-methyl-l-oxopropyl)amint>]-4-
`fluorobenzeneacetic acid, ethyl esten 90-MHz NMR (CfiCls) &
`12. (m, 9 H), 1.7 (m, 2 H), 2.85 (m, 1 H), 3.35 (m, 2 H), 3.80 (m,
`4 H), 4.20 (q, 2 H, J * 7 Hz), 4.60 (t, 1 H, J = 4.5 Hz), 5.81 (s,
`1 H), 6.8-7.3 (m, 4 H) ppm.
`A solution of this ester (35 g) and 12 g (300 mmol) of NaOH
`in 480 mL of 5:1 methanol-water was stirred and heated at reflux
`for 2 h. The solution was cooled to room temperature, concen­
`trated, and diluted with 500 mL of water. The resulting solution
`was extracted with ether. The aqueous layer was then acidified
`with ice-cold 6 M HC1 and extracted with ethyl acetate (2 x 300
`mL).
`The combined ethyl acetate extracts were washed with brine,
`dried, filtered, and evaporated to yield 30 g of crude 15 as a gum
`which was used without further purification: 90-MHz NMR
`(CDCI3) 5 1.11 (d, 6 H, J = 7 Hz), 1.4-1.9 (m, 2 H), 2.85 (m, 1
`H), 3.32 (m, 2 H), 3.75 (m, 4 H), 4.52 (t, 1 H, J = 4.5 Hz), 5.73
`(s, 1 H), 6.8-7.3 (m, 4 H) ppm.
`l-[2-(l,3-Dioxolan-2-yl)ethyl]-5-(4-fluorophenyl)-2-(l-,
`methylethyl)-iV,4-diphenyl-lH-pyrrole-3-carboxainide (16b).
`A solution of 95 g (260 mmol) of 15 and 98 g (439 mmol) of
`//,3-diphenylpropynamide21 in acetic anhydride (200 mL) was
`heated at 90 0C with stirring for 4 h (vigorous gas evolution). The
`mixture was then cooled to room temperature, concentrated, and
`chromatographed twice on silica gel (4:1 v/v hexane-ethyl acetate)
`to separate the product (fy = 0.35,4:1 hexane-ethyl acetate) from
`the N,3*diphenylpropynamide (fy = 0.5). Recrystallization of the
`product from isopropyl ether provided 59.5 g (119 mmol) of 16b
`as colorless crystals: mp 159-162 0C; 200-MHz NMR (CDCI3)
`6 1.54 (d, 6 H, J = 7 Hz), 1.91 (m, 2 H), 3.60 (septet, 1 H, J =
`7 Hz), 3.7-4.1 (m, 6 H), 4.74 (t, 1 H, J = 4.3 Hz), 7.0-7.3 (m, 15
`H); IR (KBr) 3400,1658,1596,1530 cm"1. Anal. C, H. N.
`5-«-Fluorophenyl)-2-(l-methylethyI)-l-(3-oxopropyl)-
`AM-diphenyMH-pyrrole-S-carboxamide (17c). A solution
`of 59 g (118 mmol) of 16c and 0.4 mL of concentrated HC1 in 1200
`mL of absolute ethanol was heated under reflux with stirring for
`24 h. The mixture was cooled to room temperature and con­
`centrated and the residue taken up in 3:1 acetone-water (1200
`mL). p-TSA-HoO (5 g) was added. This mixture was heated
`under reflux with stirring for 2 days, cooled to room temperature,
`and partitioned between ether (1000 mL) and brine (200 mL).
`The organic layer was separated, washed successively with sat­
`urated aqueous bicarbonate (2 x 200 mL) and brine (100 mL),
`dried, filtered, and concentrated. The resulting oil was dissolved
`in the minimum amount of hot isopropyl ether, and the crystals
`which formed upon cooling were collected by filtration to yield
`36.8 g (81 mmol) of 17e, mp 164-5 ®C. A further crop of 9.8 g
`was obtained from the mother liquor: 200-MHz NMR (CDClj)
`61.52 (d, 6 H, J = 7 Hz), 2.68 (br t, 2 H, J = 4 Hz), 3.63 (septet,
`1H, J = 7 Hz), 4.27 (br t, 2 H, J = 4 Hz), 6.86 (br s, 1H), 7.0-7.2
`(m, 14 H), 9.60 (s, 1 H); IR (KBr) 3400,2966,1720,1673,1596,
`1511 cm"1. Anal. C, H, N.
`Methyl 7-[2-(4-Fluorophenyl)-5-(l-methylethyl)-3-
`phenyl-4-[(phenylamino)carbonyl3-lflp-pyrrol-l-yl]-3-
`hydroxy-5-oxo-l-heptanoate. A solution of methyl acetoacetate
`(26.4 mL, 243 mmol) in 250 mL of anhydrous THF was added
`dropwise to a stirred suspension of hexane-washed sodium hydride
`(6.4 g, 267 mmol) in 200 mL of THF at 0 0C. When gas evolution
`was complete, 97.2 mL of a 2.5 M solution of n-butyllithium in-
`hexanes was added dropwise over 1 h.
`The resulting solution was stirred for 30 min at 0 0C and cooled
`to -78 cC, and a solution of 36.8 g (81 mmol) of 17c in 100 mL '
`of THF was added over a period of 30 min. The resulting solution
`was stirred for 30 min at -78 0C, then warmed to 0 0CI and held
`for an additional 1 h.
`
`'
`
`(21) Cabre, J.; Palomo, A, L. Synthesis 1984, 413-7.
`
`521
`
`d, J « 7 Hz, 6 H), 1.8-2.5 (m, 3 H)t 3.45 (br dd, J « 6, 8 Hz, 1
`H), 3.72 (s, 3 H), 3.80 (m, 6 H), 4.80 (m, 1 H), 6.9-7.5 (m, 4 H)
`ppm.
`A solution of this methyl ester (1 g, 2.83 mmol) and NaOH (0.4
`g, 10 mmol) in 10 mL of 4:1 methanol-water was stirred and
`heated at reflux for 3 h. The cooled solution was diluted with
`water and extracted with ether. The aqueous layer was acidified
`with 6 M HC1 and extracted with ethyl acetate (2x). The com­
`bined ethyl acetate extracts were washed with brine and dried.
`Filtration and concentration provided 0.96 g (2.8 mmol) of 10 as
`(CDCI3) B 0.85 (m, 6 H), 1.8 (m, 2 H), 2.5
`a gum:
`(m, 1 H), 3.3-3.9 (m, 7 H), 4.6 (m, 1H), 6.8-7.4 (m, 4 H) ppm.
`Dimethyl l-[2-(lf3-Dioxolan-2-yl)ethyl]-2-(4-fluoro-
`phenylJ-S-U-methylethylJ-lH-pyrrole-S^-dicarboxylate
`(11a). Dimethyl acetylenedicarboxylate (1.3 tnL, 10.6 mmol) was
`added to a solution of 10 (1.8 g, 5.28 mmol) in 10 mL of acetic
`anhydride at room temperature. Carbon dioxide evolution began
`immediately. The solution was stirred a farther 2 h, concentrated
`to remove excess dimethyl acetylenedicarboxylate and solvent,
`and then filtered through silica gel. This provided 2 g (89%) of
`11a as a colorless solid. Reaystallization from isopropyl ether-
`hexane afforded colorless crystals: mp 143-146 "C; IR (KBr) 1719,
`1449,1241,1209,1178,945 cm"1; 200-MHz NMR (CDCI3) S 135
`(d, J = 7 Hz, 6 H), 1.80 (m, 2 H), 3.18 (septet, J = 7 Hz, 1 H),
`3.56 (s, 3 H), 3.7 to 4.0 (m, 6 H), 3.83 (s, 3 H), 4.64 (t, J = 4 Hz,
`1 H), 7-7.3 (m, 4 H) ppm. Anal. C, H, N.
`•
`Dimethyl 2-(4-Fluorophenyl)-5-(l-inethylethyl)-l-(3-oxo-
`. propyl)-li7-pyrrole-3,4-dicarboxylate (12a). A solution of 11a
`(0.5 g, 1.18 mmol) and p-TSAHH^O (0.23 g, 1.2 mmol) in 12 mL
`of 5:1 acetone-water was stirred and heated at reflux for 48 h.
`The cooled solution was concentrated, diluted with ether (200
`mL), washed with saturated aqueous bicarbonate (2 x 50 mL)
`and brine (50 mL), and dried. Flash chromatography on silica
`gel (4:1 v/v hexane-ethyl acetate) provided 0.4 g (90%) of pure
`12a: 90-MHz NMR (CDCI3) 11.35 (d, J = 7 Hz, 6 H), 2.61 (t,
`J « 7 Hz, 2 H), 3.18 (septet, J = 7 Hz, 1 H), 3.53 (s, 3 H), 3.81
`(s, 3 H), 4.03 (t, J = 7 Hz, 2 H), 6.9-7.3 (m, 4 H), 9.45 (s, 1 H)
`ppm.
`Ethyl l-[2-(l,3-Dioxolan-2-yl)ethyl]-2-(4-fluorophenyI)-
`5-(l-methylethyl}*4-phenyl-lJ7-pyrrole-3-carboxylate (11c).
`A mixture of 10 (3.0 g, 8.8 mmol), acetic anhydride (15 mL), and
`' ethyl phenylpropiolate (3.0 g, 17.6 mmol) was stirred at 110 "C
`for 5 h. The solution was then cooled and the excess acetic
`anhydride removed under vacuum. The residual dark oil was
`purified by flash chromatography on silica gel (4:1 v/v ethyl
`acetate-hexane). The product solidified on standing and was
`reciystallized from ether-hexane. The first crop gave 2.2 g (30%)
`of pure lie: 90-MHz NMR (CDClj) $ 0.65 (t, 3 H, J = 7 Hz),
`1.10 (d, 6 H, J = 7 Hz), 1.7-2.0 (m, 2 H), 3.00 (septet, 1 H, J =
`7 Hz), 3.6-4.0 (m, S H), 4.60 (t, 1 H, J = 4 Hz), 6.9-7.4 (m, 9 H)
`ppm.
`Method C. Ethyl a-[[2-(l,3-Dioxolaii-2-yl)ethyl]aniino]-
`4-fluorobenzeneacetate (14). A solution of 26 g (220 mmol)
`of 2-(2-aminoethyl)-l,3-dioxolane in 50 mL of acetonitrile was
`added at room temperature with stirring to a solution of 52 g (200
`mmol) of ethyl ir-bromo-^fluorobenzeseacetate30 and 42 mL (300
`mmol) of triethylamine in 350 mL of acetonitrile. The resulting
`mixture was stirred at room temperature overnight and then
`poured into ether (500 mL). The suspension which resulted was
`washed with water (300 mL) and 2 M HC1 (2 x 300 mL). The
`combined addic extracts were made alkaline with 25% aqueous
`NaOH and extracted with ethyl acetate (2 x 500 mL). The ethyl
`acetate extracts were combined, washed successively with water
`and brine, and dried. Filtration and concentration yielded 49.5
`g (82£%) of 14 as an oil: 90-MHz NMR (CDClj) 6 1.18 (t, 3 H,
`<7 = 7 Hz), 1.85 (m, 2 H), 2^0 (br s, 1 H), 2.6 (m, 2 H), 3.85 (m,
`4 H), 4.1 (q, 2 H, J = 7 Hz), 4.22 (s, 1H), 4.83 (t, 1 H, J = 4.5
`Hz), 6.8-7.3 (m, 4 H) ppm.
`ff-[{2-(l,3-Dioxo]an-2-y])ethy]3(2-methy]-l-oxopropyl)-
`&mino]-4-flaorobenzeneacetic Acid (15). 14 (30 g, 100 mmol)
`was dissolved in 200 mL of C^Clj with 28.6 mL (205 mmol) of
`
`(20) Epstein, J. W.; Brabander, H. J.; Fanshawe, W. J.; Hofmann,
`C. M.; McKenzie, T. C.; Saiir, S. R.; Osterberg, A. C.; Cosulich,
`D. B.; Lovell. F. M. J. Med. Chem. 1981,24, 481-90.
`
`p
`
`ft
`K
`
`S"
`
`.
`
`J
`
`j
`
`:
`
`5ifr
`
`Sawai Ex 1005
`Page 3015 of 4322
`
`

`
`m n . -
`
`•
`
`364 Journal of Medicinal Chemistry, 1991, Vol. $4, No. 1
`
`The mixture was then ecidiiied by the dropwise addition of
`300 mL of ice-cold 3 M HC1, diluted with ether, washed with water
`and brine, dried, filtered, and evaporated. Flash chromatography
`on silica gel (3:1 v/v hexane-ethyl acetate) yielded 37.9 g of methyl
`7-[2-(4-fluorophenyl)-5-(l-methylethyl)-3-phenyl-4-[(phenyl-
`amino)carbonyl]-ltf-pyiTol-l-yl]-5-hydroxy-3-oxo-l-heptaiioate:
`90-MHz NMR (CDCI3) 6 1.50 (d, 6 H, J = 7 Hz), 1.8 (m, 2 H),
`2.45 (d, 2 H, J = 7 Hz), 2.8 (br s, 1 H), 3.33 {s, 2 H), 3.5 (m, 1
`H), 3.67 {s, 3 H), 3.8-4.0 (m, 2 H), 6.8-7.3 (m, 14 H) ppm.
`(i)-traiis-5-(4-Fluorophenyl)-2-(l-iaethylethyl)-JV,4-di-
`phenyl-l-[2-(tetrahydrCH4-hydroxy-6-oxo-2F-pyran-&-yl)-
`ethyl]-l£r-pyrroIe-3-carboxamide (3i). Air (60 mL) was
`bubbled via a syringe through a solution of methyl 7-[2-(4-
`fluorophenyl)-5-{l-methylethyl)-3-phenyl-4-[(phenylaamo)-
`carbonylJ-lH-pyrrol-l-yl)-5-hydroxy-3-oxo-l-heptanoate (48 g,
`84 mmol) and 92.5 mL of a 1M THF solution of tributylborane
`in 100 mL of anhydrous THF. The mixture was stirred overnight
`at room temperature and then cooled to -78 0C. Sodium boro-
`hydride (3.85 g, 102 mmol) was added to the cooled mixture in
`one portion. The vigorously stirred suspension was allowed to
`warm slowly to 0 0C over 3 h (vigorous gas evolution ensued).
`The dry ice-acetone bath cooling the reaction vessel was re­
`placed by an ice bath and 18.3 mL of glacial acetic add was added
`dropwise, followed by 204 mL of 3 N NaOH and 30.5 mL of 30%
`aqueous HjOi-
`The mixture was vigorously stirred and allowed to warm to
`room temperature overnight. The mixture was partitioned be­
`tween ether and water. The aqueous layer was separated, acidified,
`and extracted with ethyl acetate (2x).
`The ethyl acetate extracts were washed with brine, dried, and
`evaporated to yield crude (fl*tfl')-3,5-dihydroxy-7-[(4-fluoro-
`phenyl)-5-{l-methylethyl)-3-phenyl-4.[(phenylamino)-
`carbonyl]-lH-pynoH-yl]-l-heptanoic add which was used without
`further purification.
`The crude acid was taken up in toluene and heated at reflux
`for 6 h with azeotropic removal of water. Chromatography (silica
`gel, 1:1 v/v hexane-ethyl acetate) provided 30 g of 3i as a foamy
`solid, mp 90-97 0C.
`.
`This material was found by HPLC analysis to be a 9:1 mixture
`cis and trans isomers. Recrystailhation from toluene-ethyl acetate
`yielded essentially pure trans 3i: mp 148-9 0C; 200-MHz NMR
`(CDC13> 5 1.52 (m, 6 H), 1.6-2.0 (m, 4 H), 2.48 (br s, 1 H), 2.51
`(m, 2 H), 3.55 (septet, 1 H, J = 7 Hz), 4.0-4.2 (m, 2 H), 4.29 (m,
`1 H), 4.52 (m, 1 H), 6.90 (br s, 1 H), 7.0-7.3 (m, 14 H) ppm; IE
`(KBr) 3400,1734,1654,1597,1511 cm"1. Anal. C, H, N.
`Phenylmethyl l-[2-(l^-Dioxolan-2-yl)ethyl]-5-(4-fluoro-
`phenyl)-2-(l-methylethyl)-4-phenyl-l.H'-pyrrole-3-
`carboxylate (16a). A solution of 15 (10 g, 29 mmol) and benzyl
`phenylpropiolate (7.7 g, 44 mmol) was stirred and heated in 30
`mL of acetic anhydride at 90 ®C for 6 h. After cooling to room
`temperature, the solution was concentrated, diluted with ether,
`washed with water, saturated aqueous bicarbonate, and brine,
`and dried. Flash chromatography on silica gel (10:1 v/v hex­
`ane-ethyl acetate) provided 5.9 g (-45%) of crude 16a. Recrys-
`tallization from isopropyl ether provided 4.8 g of colorless 16a:
`mp 158-9 0C; m (KBr) 1683 cm"1; 200-MHz NMR (CDCI3) 6 0.93
`(t, 3 H, J = 7 Hz). 1.48 (d, 6 H, J - 7 Hz), 1.93 (m, 2 H), 3.50
`(septet, 1H, J = 7 Hz), 3.7-4.1 (m, 8 H), 4.71 (t, 1H, J = 4.4 Hz),
`6.95-7*2 (m, $ H) ppm. Anal. C, H, N.
`Method D.
`l-[2-(lT3-Dioxolan-2-yl)ethyl]-2-(4-fluoro-
`pheiiyl)-3,4-dimethyl-5*(l-methylethyl)-lB'-pyrrole (18). A
`solution of 11a (1.0 g, 2.37 mmol) in 5 mL of CHjClj was added
`dropwise to a stirred suspension of lithium aluminum hydride
`(0.3 g, 7.4 mmol) in 20 mL of ether at room temperature. When
`addition was complete, the mixture was heated to reflux for 30
`mln, cooled to room temperature, and quenched by dropwise
`addition of water (0.3 mL), 25% aqueous NaOH (0.2 mL), and
`water (0.9 mL). After stirring vigorously for 30 min, the mixture
`was filtered and washed well with CHjCl* The filtrated was dried,
`filtered, and concentrated, providing 0.78 g (90%) of pure diol.
`Trifluoroacetic add (5.2 mL, 67 mmol) was added to a stirred
`solution of the diol (1.23 g, 3.4 mmol) and triethylsilane (1.2 mL,
`7.5 mmol) in 10 mL of CHjClj cooled to 0 0C under dry nitrogen.
`The solution was stirred for 2 h at 0 0C before warming to room
`temperature for 1 h. It was then poured into 300 mL of 50:50
`ether-hexane and washed with saturated aqueous bicarbonate
`
`Roth et al.
`
`(3 X 50 mL) and brine (50 mL), and dried. Flash chromatography
`on silica gel (10:1 v/v hexane-ethyl acetate) provided 0.80 g (71%)
`of 18 as an oil: 90-MHz NMR (CDCI3) 6 1.32 (d, 6 H, J « 7 Hz),
`1.7-1.9 (m, 2 H), 1.86 (s, 3 H), 2.07 (s, 3 H), 3.10 (septet, 1 H, J
`»» 7 Hz), 3.7-4.0 (m, 6 H), 4.58 (t, 1 H, J = 4 Hz), 6.9-7.3 (m, 4
`H) ppm.
`Method E. Methyl 4-Methyl-3-oxo-2'(phenyl-
`methylene)pentanoate (21a). A mixture of methyl iso-
`butyzylacetate (144 g, 1 mol), benzaldehyde (116 g, 1.1 mol),
`piperidine (4 mL), and HOAc (12 mL) ia 200 mL of toluene was
`stirred and heated at reflux with azeotropic removal of water for
`3 h. The solution was cooled, poured into ether (1L), washed
`with 1M

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket